These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25883443)

  • 1. Risk of Malignancy Index (RMI) in Evaluation of Adnexal Mass.
    Javdekar R; Maitra N
    J Obstet Gynaecol India; 2015 Apr; 65(2):117-21. PubMed ID: 25883443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should cut-off values of the risk of malignancy index be changed for evaluation of adnexal masses in Asian and Pacific populations?
    Yavuzcan A; Caglar M; Ozgu E; Ustun Y; Dilbaz S; Ozdemir I; Yildiz E; Gungor T; Kumru S
    Asian Pac J Cancer Prev; 2013; 14(9):5455-9. PubMed ID: 24175841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the risk malignancy index diagnostic value in patients with adnexal masses.
    Terzić M; Dotlić J; Ladjević IL; Atanacković J; Ladjević N
    Vojnosanit Pregl; 2011 Jul; 68(7):589-93. PubMed ID: 21899180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.
    Dora SK; Dandapat AB; Pande B; Hota JP
    J Ovarian Res; 2017 Aug; 10(1):55. PubMed ID: 28806987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of IOTA Simple Rules, IOTA ADNEX Model, RMI, and Subjective Assessment for Preoperative Adnexal Mass Evaluation: The Experience of a Tertiary Care Referral Hospital.
    Vilendecic Z; Radojevic M; Stefanovic K; Dotlic J; Likic Ladjevic I; Dugalic S; Stefanovic A
    Gynecol Obstet Invest; 2023; 88(2):116-122. PubMed ID: 36716716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of the risk of malignancy index scoring systems (1-4) used in differential diagnosis of adnexal masses.
    Ozbay PO; Ekinci T; Caltekin MD; Yilmaz HT; Temur M; Yilmaz O; Uysal S; Demirel E; Kelekci S
    Asian Pac J Cancer Prev; 2015; 16(1):345-9. PubMed ID: 25640377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative evaluation and triage of women with suspicious adnexal masses using risk of malignancy index.
    Enakpene CA; Omigbodun AO; Goecke TW; Odukogbe AT; Beckmann MW
    J Obstet Gynaecol Res; 2009 Feb; 35(1):131-8. PubMed ID: 19215560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of risk of malignancy index (RMI), CA125, CA 19-9, ultrasound score, and menopausal status in borderline ovarian tumor.
    Alanbay I; Akturk E; Coksuer H; Ercan M; Karaşahin E; Dede M; Yenen MC; Ozan H; Baser I
    Gynecol Endocrinol; 2012 Jun; 28(6):478-82. PubMed ID: 22122561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of malignancy index in the evaluation of patients with adnexal masses.
    Clarke SE; Grimshaw R; Rittenberg P; Kieser K; Bentley J
    J Obstet Gynaecol Can; 2009 May; 31(5):440-5. PubMed ID: 19604425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors.
    Terzic M; Dotlic J; Likic I; Brndusic N; Pilic I; Ladjevic N; Maricic S; Arsenovic N; Maricic Z
    Taiwan J Obstet Gynecol; 2013 Jun; 52(2):253-7. PubMed ID: 23915860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of a risk of malignancy index in clinical approaches to adnexal masses.
    Simsek HS; Tokmak A; Ozgu E; Doganay M; Danisman N; Erkaya S; Gungor T
    Asian Pac J Cancer Prev; 2014; 15(18):7793-7. PubMed ID: 25292065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses.
    van den Akker PA; Zusterzeel PL; Aalders AL; Snijders MP; Samlal RA; Vollebergh JH; Kluivers KB; Massuger LF
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):422-5. PubMed ID: 21824712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The accuracy of risk malignancy index in prediction of malignancy in women with adnexal mass in Basrah, Iraq.
    Al-Asadi JN; Al-Maliki SK; Al-Dahhhan F; Al-Naama L; Suood F
    Niger J Clin Pract; 2018 Oct; 21(10):1254-1259. PubMed ID: 30297555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of malignancy index in discrimination of adnexal masses.
    Ulusoy S; Akbayir O; Numanoglu C; Ulusoy N; Odabas E; Gulkilik A
    Int J Gynaecol Obstet; 2007 Mar; 96(3):186-91. PubMed ID: 17280665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Comparison of Pelvic Mass Score and Risk of Malignancy Index-3 in Discrimination of Benign and Malignant Adnexal Masses.
    Isgandarova A; Yumru AE; Karatas S; Cakmak BD; Dundar B; Turker UA
    Sisli Etfal Hastan Tip Bul; 2020; 54(4):490-496. PubMed ID: 33364892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help.
    Valentin L; Ameye L; Savelli L; Fruscio R; Leone FP; Czekierdowski A; Lissoni AA; Fischerova D; Guerriero S; Van Holsbeke C; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2011 Oct; 38(4):456-65. PubMed ID: 21520475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential diagnosis of adnexal masses: sequential use of the risk of malignancy index and HistoScanning, a novel computer-aided diagnostic tool.
    Vaes E; Manchanda R; Autier P; Nir R; Nir D; Bleiberg H; Robert A; Menon U
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):91-8. PubMed ID: 21695741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Simple Ultrasound Rules by International Ovarian Tumor Analysis (IOTA) with RMI-1 and RMI-4 (Risk of Malignancy Index) in Preoperative Differentiation of Benign and Malignant Adnexal Masses.
    Dewangan S; Gupta S; Chawla I
    J Obstet Gynaecol India; 2024 Apr; 74(2):158-164. PubMed ID: 38707882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of parity to the risk of malignancy index score in evaluating adnexal masses.
    Yavuzcan A; Çağlar M; Özgü E; Üstün Y; Dilbaz S; Ozdemir I; Güngör T; Kumru S
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):518-22. PubMed ID: 25510694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary study: The sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses.
    Qiu L; Yang F; Luo H
    Medicine (Baltimore); 2018 Jul; 97(29):e11536. PubMed ID: 30024542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.